Naar homepage     
Chronische Cerebro-Spinale Veneuze Insufficiëntie
Aanmelden op het CCSVI.nl forum
Lees Voor (ReadSpeaker)    A-   A+
Over CCSVI.nl | Zoeken | Contact | Forum
CCSVI.nl is onderdeel van de
Franz Schelling Website
meer informatie
  
Friday, October 14, 2011 6:50 PM | Ken Torbert Volg link

Multiple Sclerosis: further confirmation of the Zamboni Method from Naples, Italy



During a session of the International Conference "Hemodyn 2011" held in Naples, Italy on October 13th in the presence of major vascular experts, are presented the preliminary results of three new studies that confirm the hypothesis of a possible correlation between Multiple Sclerosis (MS) and Chronic cerebrospinal venous insufficiency (CCSVI), discovered in 2008 by Dr. Paolo Zamboni, Director of Vascular Diseases Center, University of Ferrara.



Dr. Marcello Mancini (IBB, Institute of Biostructure and Bioimaging of the Italian National Research Council) presented the results of the study entitled "The Cerebral Circulation Time in the evaluation of neurological diseases" where, according to the author, compared with the healthy control group, MS patients showed a significant prolongation of CCT. These results suggest that a microvascular or venous outflow impairment could be associated with MS. The CEUS measurement of CCT may be useful tool to disclose cerebral microcirculatory dysfunction in MS patients.



Dr. Giuseppe Morelli Coppola (Pellegrini Hospital in Naples) presented the results of the study entitled "CCSVI and MS - preliminary results in 350 treated patients" where, according to the author, the preliminary results reveal a significant improvement in the quality of life, cognitive and fatigue, confirming the data published in 2009 by the group Zamboni-Galeotti-Salvi.



Dr. Renato Regine (Pozzuoli Hospital in Naples) has presented results of the study entitled "CCSVI, angioplastic treatment: our protocol and preliminary results" where, according to the authors, the follow up (1 e 3 months) demonstrated after the treatment a better performance of EDSS and of the Fatigue test in 20% and 23 % (EDSS) and in 65% and 76 % of the patients rispectly. After three months many patients (about 50%) demonstrated a US restenosis with loss of benefits.



New hope, therefore, for a seriously debilitating disease that today affects about 60,000 Italians, with onset in young people between 20 and 40 and thus the height of their activities.



Source:


http://www.vasculab.it/hemodyn2011/hemoprogram.htm


http://www.facebook.com/notes/alessandro-rasman/multiple-sclerosis-further-confirmation-of-the-zamboni-method-from-naples-italy/305786476102493?notif_t=note_tag